Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and intraocular pressure-lowering efficacy of brinzolamide + brimonidine fixed combination versus individual components in open-angle glaucoma or ocular hypertension
2010-024512-34Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in open-angle glaucoma (OAG) and ocular hypertension comparing Fixed combination brinzolamide + brimonidine, Brinzolamide monotherapy and Brimonidine monotherapy (3 arms). Primary endpoint: Primary safety and IOP-lowering efficacy. Started Apr 2011; status: completed.
02
Drugs
brinzolamidebrimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2010-024512-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024512-34.